PT  - JOURNAL ARTICLE
AU  - Susan Hatters Friedman
AU  - Anthony C. Tamburello
AU  - Aimee Kaempf
AU  - Ryan C.W. Hall
TI  - Prescribing for Women in Corrections
AID  - 10.29158/JAAPL.003885-19
DP  - 2019 Sep 13
TA  - Journal of the American Academy of Psychiatry and the Law Online
PG  - JAAPL.003885-19
4099  - http://jaapl.org/content/early/2019/09/13/JAAPL.003885-19.short
4100  - http://jaapl.org/content/early/2019/09/13/JAAPL.003885-19.full
AB  - Prescribing for women in jails and prisons requires special consideration and should be informed by extant evidence. Incarcerated women have higher rates of mental illness than both females in the community and incarcerated men. Medication administration concerns that may disproportionately affect female prisoners include drug–drug interactions with contraceptives, intermittent dosing schedules, and concerns about metabolic side effects. Further, pregnancy, lactation, and menopause may all affect medication choices. Incarcerated women frequently have comorbid mental illness, substance use disorders, and personality disorders. Finally, specific disorders, such as posttraumatic stress disorder, are more common in this population and merit special consideration for recognition and treatment.